Literature DB >> 24780415

Imaging techniques for the pre-surgical diagnosis of adnexal tumours.

Jeroen Kaijser1, Vincent Vandecaveye2, Christophe M Deroose3, Andrea Rockall4, Isabelle Thomassin-Naggara5, Tom Bourne6, Dirk Timmerman7.   

Abstract

A correct diagnosis of any adnexal mass is essential to triage women to appropriate treatment pathways. Several imaging techniques are available that may be used to provide an assessment of a mass before treatment, such as transvaginal ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography combined with computed tomography. In this chapter, we focus in depth on the role of transvaginal ultrasonography, as current evidence suggests it is the most appropriate initial imaging investigation to identify and characterise any mass if present in women suspected of having adnexal pathology. Subjective assessment by an experienced ultrasound examiner is the optimal approach to diagnose masses, followed by risk models and rules developed by the International Ovarian Tumor Analysis study. A group of tumours has proven difficult to classify with transvaginal ultrasound, and remain a diagnostic challenge for which accurate second-stage tests would be of value. Some studies suggest that magnetic resonance imaging (MRI), compared with other imaging modalities, may play a role in the assessment of this cohort of 'difficult to classify' adnexal masses. These studies, however, did not report quality of transvaginal ultrasonography (i.e. experience level of the examiner) and lacked uniformity in describing the criteria used to define such 'difficult' masses. On the basis of standardised terminology developed by the International Ovarian Tumor Analysis study to describe adnexal masses, as well as prediction models and rules developed in the course of the study, we propose new criteria that we can use to clearly define complex or 'difficult to classify' adnexal masses to focus the role for second-line imaging tests, such as conventional magnetic resonance imaging combined with dynamic contrast-enhanced or diffusion-weighted sequences on masses where further tests other than ultrasonography would be of value.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  [(18)F]-fluorodeoxyglucose positron emission tomography; magnetic resonance imaging; ovarian neoplasm; transvaginal ultrasonography

Mesh:

Year:  2014        PMID: 24780415     DOI: 10.1016/j.bpobgyn.2014.03.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  11 in total

1.  Immunological parameters as a new lead in the diagnosis of ovarian cancer.

Authors:  T Baert; D Timmerman; I Vergote; A Coosemans
Journal:  Facts Views Vis Obgyn       Date:  2015

2.  Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.

Authors:  Kanane Shimada; Koji Matsumoto; Takashi Mimura; Tetsuya Ishikawa; Jiro Munechika; Yoshimitsu Ohgiya; Miki Kushima; Yusuke Hirose; Yuka Asami; Chiaki Iitsuka; Shingo Miyamoto; Mamiko Onuki; Hajime Tsunoda; Ryu Matsuoka; Kiyotake Ichizuka; Akihiko Sekizawa
Journal:  Int J Clin Oncol       Date:  2017-12-13       Impact factor: 3.402

3.  Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses.

Authors:  Patrick N Pereira; Luis O Sarian; Adriana Yoshida; Karla G Araújo; Ricardo H O Barros; Ana C Baião; Daniella B Parente; Sophie Derchain
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

4.  Assessment of the performance of the O-RADS MRI score for the evaluation of adnexal masses, with technical notes.

Authors:  Patrick Nunes Pereira; Adriana Yoshida; Luís Otavio Sarian; Ricardo Hoelz de Oliveira Barros; Rodrigo Menezes Jales; Sophie Derchain
Journal:  Radiol Bras       Date:  2022 May-Jun

5.  Ultrasound features of immature ovarian teratomas: Case series and review of literature.

Authors:  S Abdullahi Idle; K Hayes; J A Ross
Journal:  Ultrasound       Date:  2020-02-11

Review 6.  O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.

Authors:  Elizabeth A Sadowski; Isabelle Thomassin-Naggara; Andrea Rockall; Katherine E Maturen; Rosemarie Forstner; Priyanka Jha; Stephanie Nougaret; Evan S Siegelman; Caroline Reinhold
Journal:  Radiology       Date:  2022-01-18       Impact factor: 11.105

Review 7.  Ovary: MRI characterisation and O-RADS MRI.

Authors:  Elizabeth A Sadowski; Katherine E Maturen; Andrea Rockall; Caroline Reinhold; Helen Addley; Priyanka Jha; Nishat Bharwani; Isabelle Thomassin-Naggara
Journal:  Br J Radiol       Date:  2021-04-30       Impact factor: 3.629

8.  Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies.

Authors:  J Kaijser
Journal:  Facts Views Vis Obgyn       Date:  2015

Review 9.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

10.  Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.

Authors:  Isabelle Thomassin-Naggara; Edouard Poncelet; Aurelie Jalaguier-Coudray; Adalgisa Guerra; Laure S Fournier; Sanja Stojanovic; Ingrid Millet; Nishat Bharwani; Valerie Juhan; Teresa M Cunha; Gabriele Masselli; Corinne Balleyguier; Caroline Malhaire; Nicolas F Perrot; Elizabeth A Sadowski; Marc Bazot; Patrice Taourel; Raphaël Porcher; Emile Darai; Caroline Reinhold; Andrea G Rockall
Journal:  JAMA Netw Open       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.